More candor urged in care of dying cancer patients

February 7, 2011 By LAURAN NEERGAARD , AP Medical Writer
This undated handout photo provided by the Moore family shows retired Pittsburgh oncology nurse Pearl Moore, right, with her daughter Cheryl. Cheryl Moore's experience watching her mother's painful cancer death persuaded her to make her own living will, and give a copy to her daughter, while she is still healthy. New guidance to cancer doctors says they need to be more candid with advanced cancer patients about when it's time for that kind of end-of-life planning, so they can better choose how to spend their remaining time. (AP Photo/Moore Family)

(AP) -- Patients don't want to hear that they're dying and doctors don't want to tell them. But new guidance for the nation's cancer specialists says they should be upfront and do it far sooner.

The American Society of Clinical Oncology says too often, patients aren't told about options like comfort care or even that their chemo has become futile until the bitter end.

To help families broach the topic, too, the group developed an easy-to-read booklet about those choices, from standard care to symptom relief, and advice about what to ask to maximize remaining time.

"This is not a 15-minute conversation, and it should not happen in the back of the ambulance on the way to the ICU at 3 in the morning," says ASCO chief executive Dr. Allen Lichter. "When everyone is well and has their wits about them, it's time to start the process."

The guidance and booklet - available at - mark an unusually strong push for planning end-of-life care, in a profession that earns more from attacking tumors than from lengthy, emotional discussions about when it's time to stop.

"This is a clarion call for . to take the lead in curtailing the use of ineffective therapy and ensuring a focus on and relief of symptoms throughout the course of illness," the guidance stresses.

But it's part of a slowly growing movement to deal with a subject so taboo that Congress' attempt to give such planning a nudge in 2009 degenerated into charges of "death panels."

Now consider a program in Pittsburgh named Closure. In so-called "community conversations," the program teaches families how to talk with each other and their doctors about what they want - and want to avoid - in their final days. Created by the Jewish Healthcare Foundation, sessions have spread to hospitals, religious centers and neighborhoods around the city, and a website opened last month at .

The sessions are frank. Doctors tell of entering hospital rooms late at night asking for resuscitation preferences should a very ill patient worsen only to find relatives didn't know their loved one was that sick.

"There is going to be, over the next few years, a groundswell of people telling physicians, `I don't want to go out in excruciating pain, short of breath, alone, surrounded by lights and sirens and people pounding on my chest,'" predicts Dr. Jonathan Weinkle, a primary care physician who advises the program.

"Everybody wants a good death but not a moment too soon, but they don't have the language to ask for it."

Closure participant Pearl Moore, a retired Pittsburgh oncology nurse, urges people to start planning before they're ever sick, when it's easier to discuss.

Moore's mother died of stomach cancer without health workers or family ever discussing the inevitable. Haunted, she returned to college to specialize in cancer nursing. She helped her patients discuss quality of life, "to be able to live until they died, is the way I put it," Moore says.

And years ago she prepared her own living will and other health care directives, giving copies to her daughter, Cheryl, as soon as she was grown.

"Remembering my mother, we had the discussion," says Moore.

It's not clear how often the still healthy like Moore do that kind of advance planning.

But the oncology society says it isn't happening enough with the very sick. Fewer than 40 percent of advanced have what it calls a "realistic conversation" with their doctors about what to expect and their choices of care.

The consequences: Patients increasingly are receiving aggressive chemotherapy in the last two weeks of life. They're spending more of their last months hospitalized. They're not told that a lot of expensive, side effect-prone therapies buy at best a few more months.

They think palliative care - specialized care for pain, nausea, shortness of breath - means giving up when it should be offered with standard anti-tumor care.

And they're not referred to hospice until their final days. Lichter tells of a lung cancer patient who spent his last days on a ventilator, unable to say goodbye and incurring $25,000 in hospital bills, because his family called 911 when he became short of breath. Hospice care could have eased that symptom at home.

The society plans by summer to issue detailed guidelines to help doctors conduct those tough conversations. Meanwhile, among its advice for patients:

-Ask your doctor about pros and cons of different treatment options, and discuss your priorities, including quality of life, with the doctor and family. You can change your mind later.

-Ask about palliative care for symptom relief along with your chemo. A major study last summer found that combination helped advanced lung patients live a few months longer, because people who feel better can tolerate more anti-cancer treatment.

-A living will ensures health workers and family know your choices when you cannot communicate, including whether you would want such things as a feeding tube.

-Most clinical trials for experimental treatments won't admit people who've already undergone multiple treatments, so consider that option early.

More information:
Cancer group:


State advance directives:


Related Stories

Recommended for you

Targeted antibiotic use may help cure chronic myeloid leukaemia

September 19, 2017
The antibiotic tigecycline, when used in combination with current treatment, may hold the key to eradicating chronic myeloid leukaemia (CML) cells, according to new research.

Brain powered: Increased physical activity among breast cancer survivors boosts cognition

September 19, 2017
It is estimated that up to 75 percent of breast cancer survivors experience problems with cognitive difficulties following treatments, perhaps lasting years. Currently, few science-based options are available to help. In ...

Bone marrow protein a 'magnet' for passing prostate cancer cells

September 19, 2017
Scientists at the University of York have shown that a protein in the bone marrow acts like a 'magnetic docking station' for prostate cancer cells, helping them grow and spread outside of the prostate.

Researchers compose guidelines for handling CAR T cell side effects

September 19, 2017
Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects that provide a new challenge for oncologists, one addressed by a team led by clinicians at The University ...

Brain cancer breakthrough could provide better treatment

September 19, 2017
A new discovery about the most common type of childhood brain cancer could transform treatment for young patients by enabling doctors to give the most effective therapies.

A new paradigm for treating transcription factor-driven cancers

September 18, 2017
In the current issue of Proceedings of the National Academy of Sciences, researchers from Nationwide Children's Hospital describe a new paradigm for treating transcription factor-driven cancers. The study focuses on Ewing ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.